$4.96+0.36 (+7.83%)
News8/Ratings0
Price$4.96-6.45 (-56.53%)
2026-01-212026-04-24
News · 26 weeks8-67%
2025-11-022026-04-26
Mix890d
- SEC Filings5(63%)
- Insider2(25%)
- Other1(13%)
Latest news
8 items- SECSEC Form S-3 filed by Nexentis Technologies Inc.S-3 - Nexentis Technologies Inc. (0001789192) (Filer)
- SECNexentis Technologies Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders8-K - Nexentis Technologies Inc. (0001789192) (Filer)
- SECSEC Form 10-K filed by Nexentis Technologies Inc.10-K - Nexentis Technologies Inc. (0001789192) (Filer)
- INSIDERSEC Form 4 filed by Lee Eun Young4 - Nexentis Technologies Inc. (0001789192) (Issuer)
- INSIDERSEC Form 3 filed by new insider Lee Eun Young3 - Nexentis Technologies Inc. (0001789192) (Issuer)
- SECNexentis Technologies Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits8-K - Nexentis Technologies Inc. (0001789192) (Filer)
- PRNexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech PlatformVisit Nexentis at: www.nexentistech.com Neve Yarak, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (NASDAQ:NXTS), ("Nexentis" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business model, is proud to announce the launch of its new corporate website at www.nexentistech.com. This digital milestone follows the company's recent rebranding from N2OFF, Inc., and underscores its commitment to advancing mitochondrial biology for breakthroughs in precision oncology and inflammatory metabolic diseases. The newly launched website serves as a comprehensive hub for stakeholders, including investors,
- SECSEC Form DEF 14A filed by Nexentis Technologies Inc.DEF 14A - Nexentis Technologies Inc. (0001789192) (Filer)